Ligustilide inhibits vascular smooth muscle cells proliferation

European Journal of Pharmacology

Volumn 542, Issue 1-3, 2006, Pages 136-140

  Lu, Qun ^a,b   Qiu, Tai Qiu ^a   Yang, Hong ^b  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Ligustilide; Mitogen activated protein kinase; Vascular smooth muscle cell

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTIOXIDANT; CATALASE; LIGUSTILIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVATION; INHIBITION KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

4-BUTYROLACTONE; ANIMALS; ANTHRACENES; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FLAVONOIDS; IMIDAZOLES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PYRIDINES; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RETINOBLASTOMA PROTEIN;

EID: 33746000417     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.04.023     Document Type: Article

References (31)

1. Bogoyevitch M.A. Signaling via stress activated mitogen-activated protein kinases in the cardiovascular system. Cardiovasc. Res. 45 (2000) 826-842
2. Boulton T.G., Nye S.H., Robbins D.J., Radziejewska E., Morgenbesser S.D., DePhino R.A., Panayotatos N., Cobb M.H., and Yancopoulos G.D. ERKs: a family of protein serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65 (1991) 663-675
3. Chang M.W., Barr E., Lu M.M., Barton K., and Leiden J.M. Adenovirus-mediated overexpression of the cyclin/cyclin-dependent kinase inhibitor, p21, inhibits vascular smooth muscle proliferation and neointimal formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96 (1995) 2260-2268
4. Dimmeler S., and Zeiher A.M. Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors. Regul. Pept. 90 (2000) 19-25
5. Eguchi S., and Inagami T. Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul. Pept. 91 (2000) 13-20
6. Fan L., Sun J.H., Wang C.N., and Qian G.Z. Effect of extract liquid of Ligusticum chuanxiong and Angelica sinensis on rat model of acute cerebral infarction. Chin. J. Clin. Pharmacol. 11 (2002) 81-83
7. Griendling K.K., and Harrison D.G. Dual role of reactive oxygen species in vascular growth. Circ. Res. 85 (1999) 562-563
8. Han J., Bibbs L., and Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265 (1994) 808-811
9. Hiebert S.W., Chellappen S.P., Horowitz J.M., and Nevins J.R. The interaction of RB with E2F coincides with inhibition of the transcriptional activity of E2F. Genes Dev. 6 (1992) 177-185
10. Huang W.H., and Song C.Q. Advances of Angelica sinensis chemical and pharmacology. Chin J. Chin. Mater. Med. 26 (2001) 147-151
11. Hu C.Y., and Ding X.L. Extraction, isolation and structure identification of ligustilide from Angelica sinensis. J. Wuxi Univ. Light Indust. 22 (2003) 22-24
12. Hunter T., and Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79 (1994) 573-582
13. 2-induced egr-1, fra-1, and c-jun gene expression is mediated by tyrosine kinase in aortic smooth muscle cells. Free Radic. Biol. Med. 29 (2000) 736-746
14. Kyaw M., Yoshizumi M., Tsuchiya K., Kirima K., Suzaki, Abe S., and Tamaki T. Antioxidants inhibit endothelin-1(1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1). Biochem. Pharmacol. 64 (2002) 1521-1531
15. Kyriakis J., and Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369 (1994) 156-160
16. Lavoie J.N., Allemain G.L., Brunet A., Muller R., and Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271 (1996) 20608-20616
17. Lee J.S., Liu J.J., Hong J.W., and Wilson S.E. Differential expression analysis by gene array of cell cycle modulators in human corneal epithelial cells stimulated with epidermal growth factor (EGF), hepatocyte growth factor (HGF), or keratinocyte growth factor (KGF). Curr. Eye Res. (2001) 2369-2376
18. Newby A.C., and George S.J. Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies. Cardiovasc. Res. 27 (1993) 1173-1183
19. Peters G. The D-type cyclins and their role in tumorigenesis. J. Cell Sci. 18 (1994) 89-96
20. Ross R. The pathogenesis of atherosclerosis. An update. N. Engl. J. Med. (1986) 314488-314500
21. Sherr C.J. G1 phase progression: cycling on cue. Cell 79 (1994) 551-555
22. Su B., and Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8 (1996) 402-411
23. Sun R.Z., and Wang R.Q. Reperfusion injury effect of Angelica sinensis and ligustrazine on skeletal muscle of rabbit. J. Chin. Trad. Med. Infor. 7 (2002) 30-31
24. 2 for platelet derived growth factor signal transduction. Science 270 (1995) 296-299
25. Tanner F.C., Yang Z.Y., Duckers E., Gordon D., Nabel G.J., and Nabel E.G. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ. Res. 82 (1998) 396-403
26. Tsai J.C., Jain M., Hsieh C.M., Lee W.S., Yoshizumi M., Patterson C., Perrella M.A., Cooke C., Wang H., Haber E., Schlegel R., and Lee M.E. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J. Biol. Chem. 271 (1996) 3667-3670
27. Waga S., Hannon G.L., Beach D., and Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369 (1994) 574-578
28. Wang Z.B., Castresana M.R., Detmer K., and Newman W.H. An IkB-a mutant inhibits cytokine gene expression and proliferation in human vascular smooth muscle cells. J. Surg. Res. 102 (2002) 198-206
29. Yan S., and Qiao G.F. Effect of the oil of Angelica sinensis on contractial function of isolated uterine smooth muscle of mice. Chin. Tradit. Herb. Drugs 31 (2000) 604-606
30. Zhang X., and Tenne T.E. Inhibition of rat vascular smooth muscle cell proliferation by taurine and taurine analogues. Biochem. Pharmacol. 57 (1999) 1331-1339
31. Zieske J.D., Francesconi C.M., and Guo X.Q. Cell cycle regulators at the ocular surface. Exp. Eye Res. 78 (2004) 447-456